z-logo
open-access-imgOpen Access
Late recurrence of hepatocellular carcinoma after liver transplantation
Author(s) -
Julia A. Zhang,
Sandi A. Kwee,
Linda L. Wong
Publication year - 2017
Publication title -
hepatoma research
Language(s) - English
Resource type - Journals
eISSN - 2454-2520
pISSN - 2394-5079
DOI - 10.20517/2394-5079.2017.05
Subject(s) - medicine , hepatocellular carcinoma , liver transplantation , pathogenesis , transplantation , gastroenterology , general surgery , oncology , pathology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and liver transplant (LT) prolongs survival. However, 15-20% will experience recurrent HCC, most occurring within 2 years of LT. HCC patients with late recurrences (>5 years after LT) may have distinctive clinical/biological characteristics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom